SCHEMBL27441064

SCHEMBL27441064

CCCCCCOc1c(Br)cc(C=C(C#N)C#N)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 5/20 0.57
▸ ALDH1A1 P00352 7/20 0.53
▸ MEN1 O00255 5/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ HPGD P15428 2/20 0.53
▸ HTT P42858 1/20 0.53
▸ KDM4E B2RXH2 4/20 0.49
▸ PKM P14618 1/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.48
▸ MAPT P10636 3/20 0.48
▸ RGS12 O14924 1/20 0.48
▸ GMNN O75496 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27441075 1.00 EGFR (0.57) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27441083 1.00 EGFR (0.57) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27441088 1.00 EGFR (0.57) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27440566 0.89 ALDH1A1 (0.52) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27440577 0.89 ALDH1A1 (0.52) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27440574 0.89 ALDH1A1 (0.52) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27440579 0.89 ALDH1A1 (0.52) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27441079 0.85 KDM4E (0.71) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27441069 0.83 PTP4A1 (0.59) EGFRALDH1A1MEN1KMT2AHPGD
SCHEMBL27441085 0.83 PTP4A1 (0.59) EGFRALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030877-B2 Prostaglandin E synthase inhibitors and methods for utilizing the same UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2024-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030877-B2 Prostaglandin E synthase inhibitors and methods for utilizing the same PTGES, PTGS1, PTGES2 EGFR 4261/4885ALDH1A1 474/4885MEN1 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback